Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
With the obesity epidemic contributing to rising rates of diabetes, heart disease and other chronic conditions, GLP-1 therapies represent a potential turning point in the fight against these diseases
Synthesis and Purity Sourced to clinical standards, ensuring 99%+ analytical purity via third-party HPLC verification
Studies have also shown that people with better Vitamin D levels have better mental function in their older years along with a healthier body weight
In clinical trials of Tirzepatide, a dual-acting GLP-1 and GIP agonist currently prescribed for Type 2 diabetes, obese patients lost 21 percent body mass in 1.4 years, surpassing the 15 percent reduction seen with Semaglutide
Mechanism of Action Semaglutide works by binding to GLP-1 receptors in the body
US$ 25.52
US$ 20.21
US$ 22.22
US$ 24.54
